Original Article
Efficacy and toxicity of gemcitabine plus nab-paclitaxel in patients with metastatic pancreatic adenocarcinoma after disease progression on FOLFIRINOX: a single-center analysis
Annals of Pancreatic Cancer
2025;
8:
13
.
(30 September 2025)
Editorial Commentary
Another chapter in the tale of FOLFIRINOX in the management of pancreatic ductal adenocarcinoma: do the results in the locally advanced setting fall short of expectations?
Annals of Pancreatic Cancer
2025;
8:
12
.
(30 September 2025)
